Medically reviewed by Sanja Jelic, MDA solitary pulmonary nodule (SPN) is an isolated lung growth surrounded by normal tissue. Most SPNs are benign (not cancerous) when they're diagnosed. However, ...

Initial evaluation consists of a detailed history, physical exam and review of old and new images, as well as a chest CT scan with thin 1 mm slices through the lung nodules. Multiple models are ...

SOLITARY pulmonary nodules have caused considerable concern ever since the advent of roentgenography made their detection possible during life. This concern has been heightened in recent years by the ...

A solitary lung nodule (SLN) is seen in 1 in 500 chest radiographs. Benign causes include infectious granulomas and hamartomas, and less commonly, rheumatoid nodules, intrapulmonary lymph nodes and ...

Examination of the influence that lymphatic and venous involvement gives consequence of stage I non small-cell lung cancer in new TNM classification. Background: The multidisciplinary lung cancer ...

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx. Multiple strategies are currently being used to manage patients who present with indeterminate solitary pulmonary ...

This study assessed the use of positron emission tomography (PET) in identifying and diagnosing solitary pulmonary nodules (SPNs). For this a decision analysis model was constructed, and three ...

A new technology using a special dye and near infrared imaging is enabling surgeons to precisely locate and remove small lung ...

Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, researchers report. Using tiny ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...

We reviewed the records of 39 patients treated at three major centres for recurrent osteosarcoma with a single pulmonary metastasis more than 1 year after diagnosis. We analysed their outcomes with ...

PARIS & SAN JOSE, CALIF.--(BUSINESS WIRE)--Broncus Medical, Inc., developer of diagnostic and therapeutic technologies for lung disease, today announced new data unveiled at the European Respiratory ...